Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Harvard Business School
Boehringer Ingelheim
Dow
AstraZeneca

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

US Patent Family Members and Approved Drugs for United States of America Patent: 2007172897

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US Patent Family Members and Approved Drugs for United States of America Patent: US2007172897

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
US Patent Number Estimated Patent Expiration Generic Name US Applicant US Tradename
  Start Trial 2021-03-07 infliximab Centocor Inc REMICADE
  Start Trial 2021-03-07 adalimumab Abbvie Inc HUMIRA
  Start Trial 2021-03-07 golimumab Centocor Ortho Biotech Inc SIMPONI
  Start Trial 2021-03-07 golimumab Janssen Biotech SIMPONI ARIA
  Start Trial 2021-03-07 adalimumab Abbvie Inc HUMIRA
>US Patent Number >Estimated Patent Expiration >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.